SCHEMBL21101918

SCHEMBL21101918

CC(=O)Cc1cc(C(C)(C)F)cc(C(C)(C)F)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 4/20 0.37
RXRA P19793 3/20 0.35
RXRB P28702 3/20 0.35
RXRG P48443 3/20 0.35
IDO1 P14902 2/20 0.34
POLB P06746 1/20 0.34
CYP2C19 P33261 3/20 0.34
USP2 O75604 2/20 0.34
CYP1A2 P05177 2/20 0.34
HPGD P15428 1/20 0.33
CES2 O00748 1/20 0.33
CYP2D6 P10635 1/20 0.33
PSEN1 P49768 1/20 0.33
PSEN2 P49810 1/20 0.33
APH1B Q8WW43 1/20 0.33
NCSTN Q92542 1/20 0.33
APH1A Q96BI3 1/20 0.33
PSENEN Q9NZ42 1/20 0.33
CYP3A4 P08684 1/20 0.32
GRIA2 P42262 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21101912 0.94 TACR1 (0.35) TACR1RXRARXRBRXRGIDO1
SCHEMBL21101913 0.88 MEN1 (0.34) TACR1CYP2C19CYP1A2CYP2D6CYP3A4
SCHEMBL6492340 0.86 IDO1 (0.48) TACR1RXRARXRBRXRGIDO1
SCHEMBL4286759 0.83 RXRA (0.49) RXRARXRBRXRGPOLBCYP2C19
SCHEMBL21101909 0.82 CYP1A2 (0.50) IDO1CYP2C19CYP1A2
SCHEMBL21101910 0.80 POLB (0.46) RXRARXRBRXRGPOLBCYP2C19
SCHEMBL12301741 0.76 TACR1 (0.40) TACR1RXRARXRBRXRGIDO1
SCHEMBL7356993 0.76 RXRA (0.49) TACR1RXRARXRBRXRGIDO1
SCHEMBL21101915 0.74 TACR1 (0.36) TACR1CYP2C19CYP1A2CYP2D6PSEN1
SCHEMBL21101768 0.74 RXRA (0.44) RXRARXRBRXRGPOLBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019111225-A1 COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS AVALIV THERAPEUTICS (US) 2019-06-13 WO disclosed